US Broker Ratings

Biohaven Ltd. (BHVN) Stock Analysis: Unpacking a 163.56% Potential Upside for Savvy Investors

Biohaven Ltd. (NYSE: BHVN) has captured the attention of the investment community with its robust portfolio of innovative therapies spanning various critical areas such as neuroscience, immunology, and oncology. At..

ImmunityBio, Inc. (IBRX) Stock Analysis: Exploring a 283% Upside Potential in the Biotech Sector

Investors eyeing the biotechnology sector may want to take a closer look at ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage biotech company with a focus on innovative therapies to enhance natural..

Liquidia Corporation (LQDA) Stock Analysis: Navigating 62% Upside Potential Amidst Robust Revenue Growth

Liquidia Corporation (NASDAQ: LQDA) continues to capture the attention of investors with its promising growth trajectory and impressive 62.08% potential upside, according to analyst ratings. This biopharmaceutical company, specializing in..

AdaptHealth Corp. (AHCO) Stock Analysis: Navigating a 38% Potential Upside in the Healthcare Sector

AdaptHealth Corp. (NASDAQ: AHCO), a significant player in the healthcare sector, primarily focuses on distributing home medical equipment (HME) and associated services across the United States. With a market capitalization..

SS Innovations International (SSII) Stock Analysis: A Healthcare Innovator with 121.80% Revenue Growth

SS Innovations International, Inc. (SSII) stands out as a dynamic player in the healthcare sector, specifically within the medical devices industry. Based in Gurugram, India, this commercial-stage surgical robotics company..

Kestra Medical Technologies (KMTS) Stock Analysis: A 51.5% Revenue Growth Powering the Healthcare Innovator

Kestra Medical Technologies, Ltd. (KMTS), a forward-thinking player in the healthcare sector, has been garnering significant attention for its remarkable revenue growth and innovative approach to cardiovascular care. With a..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Navigating a High Upside Potential with 89.75% Gain

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biotechnology company specializing in innovative eye condition therapies, is making waves in the healthcare sector with its intriguing financial metrics and significant growth potential...

Vericel Corporation (VCEL) Stock Analysis: Exploring a 48.46% Potential Upside in Biotech Innovation

Vericel Corporation (NASDAQ: VCEL) stands out in the healthcare sector with its pioneering efforts in cellular therapies and specialty biologic products. As a commercial-stage biopharmaceutical company based in Cambridge, Massachusetts,..

Adaptive Biotechnologies (ADPT) Stock Analysis: A Biotech Pioneer with a 36% Revenue Growth Potential

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a notable player in the biotechnology sector, has captured investor attention with its innovative approach to diagnostics and treatment. This Seattle-based company, specializing in immune..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: A Biotech Gem with 31% Upside Potential

Xenon Pharmaceuticals Inc. (NASDAQ: XENE) has emerged as a compelling player within the biotechnology sector, specifically targeting the neuroscience domain. Headquartered in Burnaby, Canada, this biopharmaceutical company focuses on the..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Revenue Growth Shines Amidst Biotech Market Dynamics

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a Canadian-based biopharmaceutical company, has garnered significant attention from investors due in part to its promising revenue growth and potential breakthroughs in autoimmune disease therapies...

Acadia Healthcare Company, Inc. (ACHC) Stock Analysis: A Potential 27.61% Upside Sparks Investor Interest

Acadia Healthcare Company, Inc. (ACHC) has captured the attention of investors with its notable potential upside of 27.61%. As a prominent player in the medical care facilities industry, Acadia Healthcare..

AtriCure, Inc. (ATRC) Stock Analysis: Exploring a 37% Potential Upside with Strong Buy Ratings

AtriCure, Inc. (NASDAQ: ATRC), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, has captured investor interest with a robust 37.10% potential upside, driven..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: A Closer Look at Its 9.79% Potential Upside

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a prominent player in the healthcare sector, particularly in the medical devices industry, is gaining attention among investors. With a market capitalization of $1.47..

Teladoc Health, Inc. (TDOC) Stock Analysis: Insights into Its Current Market Position and Growth Prospects

Investors eyeing the healthcare sector’s digital transformation might find Teladoc Health, Inc. (NYSE: TDOC) an intriguing prospect. As a pioneer in the telehealth industry, Teladoc offers a broad suite of..

Apellis Pharmaceuticals (APLS) Stock Analysis: Navigating a 27.79% Potential Upside in the Biotech Sector

Apellis Pharmaceuticals, Inc. (APLS), a key player in the biotechnology sector, continues to capture the attention of investors with its innovative approach to addressing high unmet medical needs. With a..

ICU Medical, Inc. (ICUI) Stock Analysis: Unlocking a Potential 42% Upside with Strong Buy Ratings

ICU Medical, Inc. (NASDAQ: ICUI) is catching the attention of investors with its promising upside potential and a strong consensus of buy ratings. Operating in the healthcare sector, specifically within..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Exploring a 22.78% Upside Potential Amidst Challenging Metrics

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a leader in the healthcare sector focusing on dental and medical instruments, presents a fascinating case for investors seeking opportunities in a tumultuous market. The..

National HealthCare Corporation (NHC) Stock Analysis: Resilient Revenue Growth and Strong Cash Flow Amidst Market Uncertainty

National HealthCare Corporation (NYSE: NHC), a prominent player in the medical care facilities sector, has been making waves with its impressive revenue growth and robust free cash flow. Headquartered in..

Tarsus Pharmaceuticals (TARS) Stock Analysis: A Biotech Standout with 17.91% Upside Potential

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a promising player in the biopharmaceutical sector, has caught the eye of many investors, thanks to its impressive market cap of $2.88 billion and a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds